Ozempic maker Novo Nordisk (NVO) is asking the U.S. Food and Drug Administration (FDA) to prohibit compounding pharmacies from making off-brand versions of semaglutide, the active ingredient in its blockbuster weight loss and diabetes medications.Read more…Read More
Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify on Capitol Hill Tuesday.Read More
The CEO of Novo Nordisk is defending the high cost of Ozempic and Wegovy in America, saying the blockbuster drugs are ultimately saving taxpayers money on obesity-related costs.Read More
Novo Nordisk, Europe’s largest company by market cap thanks to its wildly popular weight-loss drugs, managed just a small increase in second-quarter profits as it builds out the capacity to make the products…Read More
Novo Nordisk’s GLP-1 weight loss treatment Wegovy has been approved for use in China, opening up one of the world’s largest weight loss markets to the Danish pharma giant.Read more…Read More
Enter your details below to save your shopping cart for later. And, who knows, maybe we will even send you a sweet discount code :)
Allow notifications to get real-time updates about your shopping cart and who knows, you may even receive a sweet discount code 😊